|
ZNF572 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.69459999552902E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.236680E-04 |
| Normal-vs-Stage2 |
3.696900E-03 |
| Normal-vs-Stage3 |
1.7890999792769E-09 |
| Normal-vs-Stage4 |
3.615200000473E-07 |
| Stage1-vs-Stage2 |
6.494400E-01 |
| Stage1-vs-Stage3 |
5.73689999999738E-05 |
| Stage1-vs-Stage4 |
1.661620E-02 |
| Stage2-vs-Stage3 |
9.167700E-02 |
| Stage2-vs-Stage4 |
2.778600E-01 |
| Stage3-vs-Stage4 |
4.193800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.16080000348518E-08 |
| Normal-vs-AfricanAmerican |
4.364900E-04 |
| Normal-vs-Asian |
4.452800E-01 |
| Caucasian-vs-AfricanAmerican |
9.100400E-01 |
| Caucasian-vs-Asian |
2.740000E-01 |
| AfricanAmerican-vs-Asian |
3.379600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82720000019287E-07 |
| Normal-vs-Female |
2.39980000005247E-06 |
| Male-vs-Female |
9.579000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.319580E-02 |
| Normal-vs-Age(41-60Yrs) |
4.374400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.88119999472636E-08 |
| Normal-vs-Age(81-100Yrs) |
1.201370E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.945600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.851400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.661770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.044700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.351500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.277400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.652600E-01 |
| Normal-vs-Grade 2 |
1.378450E-03 |
| Normal-vs-Grade 3 |
3.22359999804789E-08 |
| Normal-vs-Grade 4 |
2.26210050691122E-10 |
| Grade 1-vs-Grade 2 |
2.221200E-01 |
| Grade 1-vs-Grade 3 |
5.636000E-02 |
| Grade 1-vs-Grade 4 |
1.632190E-02 |
| Grade 2-vs-Grade 3 |
2.388800E-04 |
| Grade 2-vs-Grade 4 |
2.97510000002443E-06 |
| Grade 3-vs-Grade 4 |
1.235700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.119200E-03 |
| Normal-vs-ccB subtype |
9.4717000909128E-10 |
| ccA subtype-vs-ccB subtype |
2.39460000051039E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.14759999997527E-06 |
| Normal-vs-N1 |
2.150700E-04 |
| N0-vs-N1 |
1.160970E-01 |
|
|
